Dehydroepiandrosterone supplementation attenuates ovarian ageing in a galactose-induced primary ovarian insufficiency rat model

Sözen B., Ozekinci M., ERMAN M., GUNDUZ T., DEMİR N., AKOURI R.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, cilt.36, sa.10, ss.2181-2189, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 10
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1007/s10815-019-01560-4
  • Dergi Adı: JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2181-2189
  • Anahtar Kelimeler: Rat, Galactosemia, Primary ovarian insufficiency, DHEA, FOLLICLE-STIMULATING-HORMONE, GROWTH-FACTOR-I, ANDROGEN RECEPTOR, FAILURE, EXPRESSION, WOMEN, OOCYTE, ACTIVATION, NUMBER, MICE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI). The unique pathophysiology of classic galactosemia, with a severely reduced follicle pool at an early age, requires a new therapeutic approach. This study evaluated the effect of dehydroepiandrosterone (DHEA) on ovarian tissue in a galactose-induced POI rat model.